What started as a bold pitch on Shark Tank India Season 3 has now turned into one of the most talked-about health-tech success stories of 2025. FlexifyMe, the Pune-based startup blending AI and physiotherapy, has just raised a whopping Rs 20 crore ($2.4 million) in pre-Series A funding, led by IvyCap Ventures with participation from Signal Ventures and existing backers.
This latest boost comes hot on the heels of its earlier $1 million seed round led by Flipkart Ventures—and yes, the same company that caught the attention of Shark Tank judge Namita Thapar, who placed her bets on its future.
AI + Physiotherapy = A Pain-Free Revolution
FlexifyMe, founded in 2021 by Manjeet Singh and Amit Bhayani, is rewriting the rules of musculoskeletal care. Instead of relying on vague, symptom-based assessments, the startup uses AI-powered posture and motion analysis combined with expert physiotherapy to pinpoint the real causes of chronic pain.
Its approach? Scientific, trackable, and revolutionary. Forget unnecessary surgeries and trial-and-error treatments—FlexifyMe is making the road to recovery smarter, faster, and more cost-effective.
The Big Plans Behind the Rs 20 Crore Boost
The fresh capital will fuel some ambitious moves:
- Hybrid Care Expansion: Scaling online sessions while opening more offline centers to reach patients everywhere.
- Cutting-Edge Labs: Launching advanced posture and gait analysis labs to provide real-time, precision diagnostics.
- Clinical Research Partnerships: Strengthening collaborations to back its tech with hard science and expand credibility worldwide.
“By combining technology, licensed physiotherapists and rigorous progress tracking, we are making the journey to a pain-free life scientific, objective and measurable,” said co-founder Manjeet Singh.
Why FlexifyMe is Turning Heads
- Live one-on-one sessions with certified physiotherapists.
- Personalized programs designed for long-term recovery.
- Guided video sessions blending modern tech with traditional wisdom.
- A clear mission: help millions avoid surgeries, return to their passions, and reclaim their quality of life.
It’s not just another health-tech startup. It’s a movement that could redefine how India—and the world—deals with chronic pain.
The Bigger Picture
India’s health-tech market is booming, but chronic pain solutions remain underexplored. With over 200 million Indians struggling with back, neck, and joint issues, FlexifyMe’s timing couldn’t be better. Add in its AI-first approach, and the company is poised to capture a massive slice of the global physiotherapy market.
For investors like IvyCap Ventures, the bet is simple: FlexifyMe could be the future of preventive and recovery healthcare.
From Shark Tank Spotlight to Startup Stardom
The Shark Tank boost gave FlexifyMe visibility. Now, with IvyCap’s Rs 20 crore check and Namita Thapar’s backing, the startup isn’t just surviving—it’s scaling like never before.
The question isn’t whether FlexifyMe can succeed. It’s how far—and how fast—it will go before becoming India’s next big health-tech unicorn.
